Abcam PLC
LSE:ABC
Abcam PLC
LSE:ABC
Price:
1 226 GBX
11.15%
Market Closed
Updated:
Apr 28, 2024
Abcam PLC
Cash from Operating Activities
|
Abcam PLC
Cash from Operating Activities Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abcam PLC
LSE:ABC
|
Cash from Operating Activities
£126m
|
CAGR 3-Years
22%
|
CAGR 5-Years
14%
|
CAGR 10-Years
18%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Operating Activities
-$160.3m
|
CAGR 3-Years
-147%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Operating Activities
-$145.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Operating Activities
-$60.6m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Operating Activities
£2.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash from Operating Activities
£44.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
See Also
What is Abcam PLC's Cash from Operating Activities?
Cash from Operating Activities
126m
GBP
126m
GBP
Based on the financial report for Jun 30, 2022, Abcam PLC's Cash from Operating Activities amounts to 126m GBP.
What is Abcam PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
18%
18%
Over the last year, the Cash from Operating Activities growth was 75%. The average annual Cash from Operating Activities growth rates for Abcam PLC have been 22% over the past three years , 14% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
